Merck refinances €2bn RCF with oversubscribed line
German pharmaceuticals firm Merck has refinanced a €2bn revolver maturing in 2014 with a new facility of the same size.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
